MGD-22
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


MGD-22
Description :
MGD-22, a molecular glue, is an orally active IKZF1/2/3 degrader with DC50 values of 8.33 nM, 9.91 nM, and 5.74 nM, respectively. MGD-22 exhibits extremely potent anti-proliferative activity against diverse hematological cancer cells. MGD-22 induces apoptosis in cancer cells. MGD-22 demonstrates potent anti-tumor efficacy in mice bearing NCI-H929 xenografts or WSU-DLCL-2 xenografts. MGD-22 can be used for the study of hematological cancers, including multiple myeloma (MM), acute myeloid leukemia (AML), and diffuse large B-cell lymphoma (DLBCL) [1].UNSPSC :
12352005Target :
Apoptosis; IKZF Family; Molecular GluesRelated Pathways :
Apoptosis; Immunology/Inflammation; PROTACApplications :
Cancer-programmed cell deathField of Research :
CancerSmiles :
O=C(N1)C(N2N(CC3=C(C=CC=C3C2=O)NCC4=CC=C(CN5CCN(CC5)C6=CC=C(C=C6)C#N)C=C4)C)CCC1=OMolecular Formula :
C33H35N7O3Molecular Weight :
577.68References & Citations :
[1]Wei T, et al. Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological Cancers. J Med Chem. 2025 Aug 14;68 (15) :16237-16259.Shipping Conditions :
Room temperatureScientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
IKZF1; IKZF2; IKZF3CAS Number :
[2991818-12-1]

